Ticker
ZBIOCompany Name
ZENAS BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 669.55M | $ 237.65M | $ 0 | $ 0 | -35.49% |
3/31/2025 | $ 407.46M | $ 0 | $ 0 | $ 0 | 0% |
12/31/2024 | $ 303.05M | $ 234.58M | $ 0 | $ 0 | -77.41% |
9/30/2024 | $ 861.31M | $ 0 | $ 0 | $ 0 | 0% |
12/31/2023 | $ 0 | $ 116K | $ 20M | $ 0 | 0% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for ZENAS BIOPHARMA INC is calculated as follows: (-1 * CF - Equity [ $ 116K ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 20M ]) / Market Cap [ $ 0 ]
(=) Shareholder Yield [ 0% ]
Minimum
Dec 31, 2024
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.57% |
median | 1.07% |
std | 11.13% |